Concepedia

Tom Schulz

TS

Statistics

Publications

3

Citations

54

H-Index

3

Active since

2023

Affiliations

TU Dortmund University(Current)

Max Planck Institute of Molecular Physiology

German Cancer Research Center

Deutschen Konsortium für Translationale Krebsforschung

Tom Schulz is an author at TU Dortmund University specializing in drug discovery, medicinal chemistry, and drug resistance.

ORCID

Top concepts

Publications per year

2023–2024

3

Publications

3

Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA

Alina Teuber, Tom Schulz, B. S. Fletcher et al. · Nature Communications · 2024 · 20 citations · Full text

KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines

Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber et al. · ACS Medicinal Chemistry Letters · 2023 · 15 citations · Full text

, , +14

Rows per page

1–3 of 3